Stocks can close at one price and open at triple t
Post# of 72440
This happened for DNDN on news of FDA approval of their very expensive personalized prostate cancer vaccine (over $100k per treatment).
That is not nearly as big a market as, for instance, an oral rinse that could prevent most cases of oral mucositis. In my opinion Brilacidin-OM alone is worth enough to make any shares down here become the investment of lifetime. (note: this is NOT trading advice)